Topic: Cardiomyopathy

Dr. David Martin traces the history of coronavirus research back to 1965, noting that Pfizer filed its first coronavirus vaccine patent in 1990. He details how Ralph Baric modified the virus in the late 1990s to specifically target heart tissue, leading to cardiomyopathy in test subjects. Martin asserts that the myocarditis and blood clots observed after COVID-19 vaccinations were not unintended side effects but known outcomes of the engineered spike protein technology.

In 1999, Ralph Baric modified the coronavirus protein to specifically target heart tissue, inducing cardiomyopathy in rabbits. Pfizer and other manufacturers were aware of the risks of sudden cardiac death, vascular inflammation, and clot formation based on published data from 2000. The claims that these side effects were unintended consequences are dismissed as false.

Whistleblower Ted Macy, a military health administrator, presents data from the Defense Medical Epidemiology Database (DMED) showing massive spikes in heart-related conditions among pilots. The data indicates a 151% rise in myocarditis and a 973% increase in heart failure cases in 2022 compared to the five-year average. These findings have led to the signing of a "military accountability declaration" by 231 service members.

Dr. Lindsey discusses her work in toxicology litigation and shares a historical "tidbit" linking coronaviruses to Johns Hopkins syphilis strains from the 1960s. She notes that researchers have known since 1992 that certain coronaviruses can be used to purposefully induce cardiomyopathy in animal models.